
Eli Lilly and Co
NYSE:LLY

Eli Lilly and Co?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
713.71
958.4326
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Eli Lilly and Co hold over its rivals?
What risks and challenges
does Eli Lilly and Co face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Eli Lilly and Co.
Provide an overview of the primary business activities
of Eli Lilly and Co.
What unique competitive advantages
does Eli Lilly and Co hold over its rivals?
What risks and challenges
does Eli Lilly and Co face in the near future?
Has there been any significant insider trading activity
in Eli Lilly and Co recently?
Summarize the latest earnings call
of Eli Lilly and Co.
What significant events have occurred
in Eli Lilly and Co over the past months?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Eli Lilly and Co.
Provide P/S
for Eli Lilly and Co.
Provide P/E
for Eli Lilly and Co.
Provide P/OCF
for Eli Lilly and Co.
Provide P/FCFE
for Eli Lilly and Co.
Provide P/B
for Eli Lilly and Co.
Provide EV/S
for Eli Lilly and Co.
Provide EV/GP
for Eli Lilly and Co.
Provide EV/EBITDA
for Eli Lilly and Co.
Provide EV/EBIT
for Eli Lilly and Co.
Provide EV/OCF
for Eli Lilly and Co.
Provide EV/FCFF
for Eli Lilly and Co.
Provide EV/IC
for Eli Lilly and Co.
Show me price targets
for Eli Lilly and Co made by professional analysts.
What are the Revenue projections
for Eli Lilly and Co?
How accurate were the past Revenue estimates
for Eli Lilly and Co?
What are the Net Income projections
for Eli Lilly and Co?
How accurate were the past Net Income estimates
for Eli Lilly and Co?
What are the EPS projections
for Eli Lilly and Co?
How accurate were the past EPS estimates
for Eli Lilly and Co?
What are the EBIT projections
for Eli Lilly and Co?
How accurate were the past EBIT estimates
for Eli Lilly and Co?
Compare the revenue forecasts
for Eli Lilly and Co with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Eli Lilly and Co and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Eli Lilly and Co against its competitors.
Analyze the profit margins
(gross, operating, and net) of Eli Lilly and Co compared to its peers.
Compare the P/E ratios
of Eli Lilly and Co against its peers.
Discuss the investment returns and shareholder value creation
comparing Eli Lilly and Co with its peers.
Analyze the financial leverage
of Eli Lilly and Co compared to its main competitors.
Show all profitability ratios
for Eli Lilly and Co.
Provide ROE
for Eli Lilly and Co.
Provide ROA
for Eli Lilly and Co.
Provide ROIC
for Eli Lilly and Co.
Provide ROCE
for Eli Lilly and Co.
Provide Gross Margin
for Eli Lilly and Co.
Provide Operating Margin
for Eli Lilly and Co.
Provide Net Margin
for Eli Lilly and Co.
Provide FCF Margin
for Eli Lilly and Co.
Show all solvency ratios
for Eli Lilly and Co.
Provide D/E Ratio
for Eli Lilly and Co.
Provide D/A Ratio
for Eli Lilly and Co.
Provide Interest Coverage Ratio
for Eli Lilly and Co.
Provide Altman Z-Score Ratio
for Eli Lilly and Co.
Provide Quick Ratio
for Eli Lilly and Co.
Provide Current Ratio
for Eli Lilly and Co.
Provide Cash Ratio
for Eli Lilly and Co.
What is the historical Revenue growth
over the last 5 years for Eli Lilly and Co?
What is the historical Net Income growth
over the last 5 years for Eli Lilly and Co?
What is the current Free Cash Flow
of Eli Lilly and Co?
Discuss the annual earnings per share (EPS)
trend over the past five years for Eli Lilly and Co.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
730.4B USD | 35.3 | |
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
364B USD | 12.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 13.5 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
210.1B CHF | 9.5 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
188.5B CHF | 10.6 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
161.8B GBP | 130.8 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
201.7B USD | 8.6 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 261.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
136.6B USD | 7.5 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
105.5B EUR | 4.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
Average EV/EBITDA:
394.6
35.3
|
30%
|
1.2 | |
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
12.2
|
7%
|
1.7 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13.5
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.5
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10.6
|
5%
|
2.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
130.8
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
8.6
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
261.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.5
|
2%
|
3.7 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
4.5
|
7%
|
0.6 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.